Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493961 · ClinicalTrials.gov registry record · Phase 1
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
A Phase 1 study of Kallmann Syndrome and Idiopathic Hypogonadotropic Hypogonadism, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT00493961 is a Phase 1 study of Kallmann Syndrome and Idiopathic Hypogonadotropic Hypogonadism that has completed, run by Massachusetts General Hospital. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00493961, a Phase 1 study of Kallmann Syndrome and Idiopathic Hypogonadotropic Hypogonadism, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
Men with Idiopathic Hypogonadotropic Hypogonadism (IHH) lack a hormone called gonadotropin releasing hormone (GnRH). This hormone is important for starting puberty, maintaining testosterone levels, and fertility. The purpose of this study is to research the effects of treating IHH men with GnRH for 7 days.
Conditions Studied
Interventions
- DRUG gonadotropin releasing hormone (GnRH)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 1999-01 |
| Est. Completion | 2009-11-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00493961
The ClinicalTrials.gov registry entry for NCT00493961 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Kallmann Syndrome appearing as the primary indexed condition, and to 1 intervention - of which gonadotropin releasing hormone (GnRH) is the first listed.
NCT00493961 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00493961 about?
NCT00493961 is a clinical study titled "Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism". Men with Idiopathic Hypogonadotropic Hypogonadism (IHH) lack a hormone called gonadotropin releasing hormone (GnRH). This hormone is important for starting puberty, maintaining testosterone levels, and fertility. The purpose of this study is to research the effects of treating IHH men with GnRH for ...
What is the current status of trial NCT00493961?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 1999-01. Estimated completion is 2009-11-17.
What conditions does trial NCT00493961 study?
This clinical trial studies the following conditions: Kallmann Syndrome, Idiopathic Hypogonadotropic Hypogonadism, GnRH Deficiency.
What interventions are being tested in trial NCT00493961?
The interventions under investigation include: gonadotropin releasing hormone (GnRH) (DRUG).
Who is sponsoring clinical trial NCT00493961?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00493961 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kallmann Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Kallmann Syndrome
All registered trials for this condition
Idiopathic Hypogonadotropic Hypogonadism
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.